A fixed dose combination of the LABA salmeterol plus the inhaled glucocorticoid fluticasone has no higher risk of asthma related death or hospital admission than fluticasone alone, a randomised study published in the NEJM concludes. However the findings may not apply to patients with the most severe and unstable disease because they were excluded from the ...
Fluticasone plus salmeterol safety data ‘reassuring’
By Nicola Garrett
8 Mar 2016